The stem cell manufacturing market is set to grow by USD 6.77 billion, progressing at a CAGR of 9.69% from 2021 to 2026. Technavio’s latest research report on the Stem Cell Manufacturing Market offers a comprehensive analysis of new product launches, the latest trends, drivers, and challenges. 42% of the market’s growth will originate from North America during the forecast period. The US is the key market for stem cell manufacturing in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW. The presence of a well-developed healthcare system (helps vendors providing biotechnology solutions to easily establish themselves in the market) and the high disposable income (allows people to opt for expensive stem cell therapies) will facilitate the stem cell manufacturing market growth in North America in the forecast period.
The stem cell manufacturing market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market. The stem cell manufacturing market report includes information on the product launches, sustainability, and prospects of leading vendors including Becton Dickinson and Co., Bio-Techne Corp., Corning Inc., Danaher Corp., Lonza Group Ltd., Merck KGaA, PerkinElmer Inc., Sartorius AG, STEMCELL Technologies Inc., and Thermo Fisher Scientific Inc. The stem cell manufacturing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Few companies with key offerings
Becton Dickinson and Co. – The company offers stem cell manufacturing kits namely a stem cell Enumeration kit.
Bio-Techne Corp. – The company offers stem cell manufacturing solutions such as induced Pluripotent Stem Cells, Hematopoietic stem cells among others.
Corning Inc. – The company offers stem cell manufacturing kits such as ECM Mimetic and advanced surfaces, Corning microcarriers among others.
Lonza Group Ltd. – The company offers a stem cell manufacturing kit namely a Mesenchymal stem cell growth medium bullet kit.
Merck KGaA – The company offers stem cell manufacturing solutions namely stem cell proliferation inhibitors.
To know about all major companies with their key offerings – Download a free sample now!
Factors such as rising prevalence of several chronic disorders and rising focus on regenerative medicines will be crucial in driving the growth of the market. However, the lack of trained professionals will restrict the market growth.
The competitive scenario provided in the stem cell manufacturing market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
Market Segmentation Analysis
By Deployment, the market is classified as P and BC, AI RL and CRO, H and SC, C and TB, and others
By Geography, the market is classified as North America, Europe, Asia, and ROW.
Induced Pluripotent Stem Cells Production Market -The induced pluripotent stem cells production market share should rise by USD 1.55 billion from 2022 to 2026 at a CAGR of 11.39%. Download a free sample now!
Hematopoietic Stem Cells Transplantation Market -The hematopoietic stem cells transplantation (HSCT) market share is expected to increase by USD 1.99 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 6%. Download a free sample now!
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Source : https://www.prnewswire.com/news-releases/stem-cell-manufacturing-market—42-of-growth-to-originate-from-north-america-evolving-opportunities-with-becton-dickinson-and-co–bio-techne-corp-17000-technavio-reports-301485756.html
- United Kingdom